EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H32O5 |
| Net Charge | 0 |
| Average Mass | 352.471 |
| Monoisotopic Mass | 352.22497 |
| SMILES | CCCCCC(=O)CC[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O |
| InChI | InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,16-18,22H,2-3,5-6,8-14H2,1H3,(H,24,25)/b7-4-/t16-,17-,18+/m1/s1 |
| InChIKey | VSRXYLYXIXYEST-KZTWKYQFSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Homo sapiens (ncbitaxon:9606) | blood (UBERON:0000178) | PubMed (20671299) |
| Roles Classification |
|---|
| Biological Role: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 13,14-dihydro-15-ketoprostaglandin D2 (CHEBI:72603) has functional parent prostaglandin D2 (CHEBI:15555) |
| 13,14-dihydro-15-ketoprostaglandin D2 (CHEBI:72603) has role metabolite (CHEBI:25212) |
| 13,14-dihydro-15-ketoprostaglandin D2 (CHEBI:72603) is a prostaglandins D (CHEBI:26337) |
| IUPAC Name |
|---|
| (5Z,9α)-9-hydroxy-11,15-dioxoprost-5-en-1-oic acid |
| Synonyms | Source |
|---|---|
| 13,14dh,15k-PGD2 | ChEBI |
| 11,15-dioxo-9S-hydroxy-5Z-prostenoic acid | LIPID MAPS |
| 13,14-dihydro-15-keto-PGD2 | LIPID MAPS |
| dhk-PGD2 | LIPID MAPS |
| (Z)-7-[(1R,2R,5S)-5-hydroxy-3-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid | HMDB |
| (5Z)-7-[(1R,2R,5S)-5-hydroxy-3-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid | HMDB |
| Manual Xrefs | Databases |
|---|---|
| LMFA03010022 | LIPID MAPS |
| HMDB0060042 | HMDB |
| Registry Numbers | Sources |
|---|---|
| Reaxys:3004662 | Reaxys |
| CAS:59894-07-4 | ChemIDplus |
| Citations |
|---|